One of the duodenoscope manufacturers at the center of a series of infectious outbreaks dating back to 2012 has announced plans to recall its current model and replace it with a new FDA-approved design.
For the last several years, there has been a startling mortality trend emerging in the United States: Each year, middle-aged white Americans are dying at a faster clip than any of their counterparts in different age groups, ethnicities, or countries.
Briefings on Accreditation & Quality - Volume 26, Issue 3
A good job is its own reward, but that doesn't mean recognition isn't appreciated. Last year, 1,043 hospitals (31.5% of those analyzed) were recognized by The Joint Commission's Top Performer on Key Quality Measures® program. Inclusion on the top performers' list is a huge...
How prepared are you for the Joint Commission’s new Patient Safety Systems (PSS) chapter? The most recent PSS chapter came into effect on January 2015 and the Joint Commission will expect you to be up-to-date when they come around for a survey.
On February 19, the Food and Drug Administration (FDA) announced that reprocessing instructions for Pentax duodenoscopes had been validated and approved by the agency.
To find out what physicians think of the prescription problem and how to fix it, the American Medical Association conducted a national survey on the issue.
A new report by the United Kingdom’s Review on Antimicrobial Resistance (RAR), says drug-resistant superbugs can be fought with global coverage and research of vaccines.
On February 9, 26 senators from 17 states sent a letter asking for a review of the pain management section of CMS’s Hospital Value-Based Purchasing Program (HVBPP), stating that it puts pressure on physicians to excessively prescribe opioids.
